Moberg Pharma is headquartered in Bromma, Sweden.
Moberg Pharma disclosed revenue of 10M SEK for 2024 and 439M SEK for 2018.
Moberg Pharma has 9 employees.
Moberg Pharma is a life science company.
Moberg Pharma was founded in 2006.
GustavslundsvAegen 42, 5th Floor,
Bromma,
167 51
Sweden,
+46 8 52 23 07 00
www.mobergderma.se
Moberg Pharma is a pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. Moberg Pharma was founded in 2006 and is based in Bromma, Sweden.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 7 | - | - | - | - | - | 7 |
| vol | $20M | $20M | ||||||
| Sell (0.0/yr) | # | 3 | - | - | - | - | - | 3 |
| vol | $5M | $5M | ||||||
| 10 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
